国际医药卫生导报2014,Vol.20Issue(12):1767-1770,4.DOI:10.3760/cma.j.issn.1007-1245.2014.12.045
23价肺炎球菌疫苗联合流感疫苗对COPD急性发作的临床干预
Influence of 23-valent pneumococcus vaccine combined with influenza vaccine on COPD acute outbreak
陈薇1
作者信息
- 1. 510115 广州市越秀区人民街社区卫生服务中心
- 折叠
摘要
Abstract
Objective To study the influence of 23-valent pneumococcus vaccine combined with influenza vaccine on COPD acute outbreak.Methods 69 cases of COPD in local community were randomly divided into vaccine group (36 cases) and control group (33 cases).Patients in vaccine group were vaccinated with 23-valent pneumococcus vaccine and influenza vaccine,adverse reactions were monitored for 2 weeks.All patients were followed for 1 year.days,Times,period and interval time of outbreak,hospital stay times,length of stay,severity of patients' condition and survival rate were analyzed.Results Times and severe level of outbreak significantly reduced in vaccine group (P < 0.05).Local adverse reactions were found in vaccine group,which remitted in 8-24 hours after symptomatic treatment.Conclusion 23-valent pneumococcus vaccine combined with influenza vaccine has a significant influence on COPD acute outbreak,with tolerated adverse reactions,worthy of clinical promotion.关键词
23价肺炎球菌疫苗/流感疫苗/COPD急性发作/干预Key words
23-valent pneumococcus vaccine/Influenza vaccine/COPD acute outbreak/Intervention引用本文复制引用
陈薇..23价肺炎球菌疫苗联合流感疫苗对COPD急性发作的临床干预[J].国际医药卫生导报,2014,20(12):1767-1770,4.